Conditions: Inherited Erythromelalgia
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 5
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy and safety of single doses of PF-05089771 against placebo in treatment of pain in patients with primary, inherited erythromelalgia.

Detailed description:

Arms:
arm 1: None arm 2: Single oral dose of placebo for PF-05089771 1600 mg

Interventions: intervention 1: PF-05089771 intervention 2: Placebo
Intervention descriptions: intervention 1: A single oral dose of PF-05089771 1600 mg solution to be administered on Day 1 of each treatment session. There are 2 treatment sessions, therefore 2 single oral doses of PF-05089771 will be adminstered. intervention 2: Placebo for PF-05089771 1600 mg solution administered in each treatment session. There are 2 treatment sessions, therefore 2 single oral doses of placebo will be administered.

Protocol document: